Sang-A Pharm seeking to produce generic drugs

Sang-A Pharm said that as part of diversifying its business sector and sales boost, it has recently set up FineChem., a drug synthesis corporation, with a pain-in capital of 500 million won in a bid to meet the increasing demand of generic drugs which has been influenced by the government drug-related measures to curb the use of high-priced drugs.

It further noted that the new company aims t...